BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

461 related articles for article (PubMed ID: 26368264)

  • 1. Heptadecanoylcarnitine (C17) a novel candidate biomarker for newborn screening of propionic and methylmalonic acidemias.
    Malvagia S; Haynes CA; Grisotto L; Ombrone D; Funghini S; Moretti E; McGreevy KS; Biggeri A; Guerrini R; Yahyaoui R; Garg U; Seeterlin M; Chace D; De Jesus VR; la Marca G
    Clin Chim Acta; 2015 Oct; 450():342-8. PubMed ID: 26368264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantification of 2-methylcitric acid in dried blood spots improves newborn screening for propionic and methylmalonic acidemias.
    Al-Dirbashi OY; McIntosh N; Chakraborty P
    J Med Screen; 2017 Jun; 24(2):58-61. PubMed ID: 27216769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Newborn screening for propionic, methylmalonic acidemia and vitamin B12 deficiency. Analysis of 588,793 newborns.
    Martín-Rivada Á; Cambra Conejero A; Martín-Hernández E; Moráis López A; Bélanger-Quintana A; Cañedo Villarroya E; Quijada-Fraile P; Bellusci M; Chumillas Calzada S; Bergua Martínez A; Stanescu S; Martínez-Pardo Casanova M; Ruíz-Sala P; Ugarte M; Pérez González B; Pedrón-Giner C
    J Pediatr Endocrinol Metab; 2022 Oct; 35(10):1223-1231. PubMed ID: 36112821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous determination of 3-hydroxypropionic acid, methylmalonic acid and methylcitric acid in dried blood spots: Second-tier LC-MS/MS assay for newborn screening of propionic acidemia, methylmalonic acidemias and combined remethylation disorders.
    Monostori P; Klinke G; Richter S; Baráth Á; Fingerhut R; Baumgartner MR; Kölker S; Hoffmann GF; Gramer G; Okun JG
    PLoS One; 2017; 12(9):e0184897. PubMed ID: 28915261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Useful second-tier tests in expanded newborn screening of isovaleric acidemia and methylmalonic aciduria.
    Shigematsu Y; Hata I; Tajima G
    J Inherit Metab Dis; 2010 Oct; 33(Suppl 2):S283-8. PubMed ID: 20440648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences between acylcarnitine profiles in plasma and bloodspots.
    de Sain-van der Velden MG; Diekman EF; Jans JJ; van der Ham M; Prinsen BH; Visser G; Verhoeven-Duif NM
    Mol Genet Metab; 2013; 110(1-2):116-21. PubMed ID: 23639448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative acylcarnitine determination by UHPLC-MS/MS--Going beyond tandem MS acylcarnitine "profiles".
    Minkler PE; Stoll MS; Ingalls ST; Kerner J; Hoppel CL
    Mol Genet Metab; 2015 Dec; 116(4):231-41. PubMed ID: 26458767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid 2nd-tier test for measurement of 3-OH-propionic and methylmalonic acids on dried blood spots: reducing the false-positive rate for propionylcarnitine during expanded newborn screening by liquid chromatography-tandem mass spectrometry.
    la Marca G; Malvagia S; Pasquini E; Innocenti M; Donati MA; Zammarchi E
    Clin Chem; 2007 Jul; 53(7):1364-9. PubMed ID: 17510301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diversity in the incidence and spectrum of organic acidemias, fatty acid oxidation disorders, and amino acid disorders in Asian countries: Selective screening vs. expanded newborn screening.
    Shibata N; Hasegawa Y; Yamada K; Kobayashi H; Purevsuren J; Yang Y; Dung VC; Khanh NN; Verma IC; Bijarnia-Mahay S; Lee DH; Niu DM; Hoffmann GF; Shigematsu Y; Fukao T; Fukuda S; Taketani T; Yamaguchi S
    Mol Genet Metab Rep; 2018 Sep; 16():5-10. PubMed ID: 29946514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic Challenges Using a 2-Tier Strategy for Methylmalonic Acidurias: Data from 1.2 Million Dried Blood Spots.
    Weiss KJ; Röschinger W; Blessing H; Lotz-Havla AS; Schiergens KA; Maier EM
    Ann Nutr Metab; 2020; 76(4):268-276. PubMed ID: 32683363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A False-Positive Case of Methylmalonic Aciduria by Tandem Mass Spectrometry Newborn Screening Dependent on Maternal Malnutrition in Pregnancy.
    Rossi C; Cicalini I; Rizzo C; Zucchelli M; Consalvo A; Valentinuzzi S; Semeraro D; Gasparroni G; Brindisino P; Gazzolo D; Dionisi-Vici C; De Laurenzi V; Pieragostino D
    Int J Environ Res Public Health; 2020 May; 17(10):. PubMed ID: 32443888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma methylcitric acid and its correlations with other disease biomarkers: The impact in the follow up of patients with propionic and methylmalonic acidemia.
    Maines E; Catesini G; Boenzi S; Mosca A; Candusso M; Dello Strologo L; Martinelli D; Maiorana A; Liguori A; Olivieri G; Taurisano R; Piemonte F; Rizzo C; Spada M; Dionisi-Vici C
    J Inherit Metab Dis; 2020 Nov; 43(6):1173-1185. PubMed ID: 32681732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retrospective evaluation of the Dutch pre-newborn screening cohort for propionic acidemia and isolated methylmalonic acidemia: What to aim, expect, and evaluate from newborn screening?
    Haijes HA; Molema F; Langeveld M; Janssen MC; Bosch AM; van Spronsen F; Mulder MF; Verhoeven-Duif NM; Jans JJM; van der Ploeg AT; Wagenmakers MA; Rubio-Gozalbo ME; Brouwers MCGJ; de Vries MC; Langendonk JG; Williams M; van Hasselt PM
    J Inherit Metab Dis; 2020 May; 43(3):424-437. PubMed ID: 31828787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neonatal Macrosomia is an Interfering Factor for Analytes on the Colorado State Newborn Screen.
    Wright EL; Baker PR
    J Clin Endocrinol Metab; 2020 Mar; 105(3):. PubMed ID: 32126138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Newborn screening and early biochemical follow-up in combined methylmalonic aciduria and homocystinuria, cblC type, and utility of methionine as a secondary screening analyte.
    Weisfeld-Adams JD; Morrissey MA; Kirmse BM; Salveson BR; Wasserstein MP; McGuire PJ; Sunny S; Cohen-Pfeffer JL; Yu C; Caggana M; Diaz GA
    Mol Genet Metab; 2010 Feb; 99(2):116-23. PubMed ID: 19836982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic challenges of aminoacidopathies and organic acidemias in a developing country: a twelve-year experience.
    Karam PE; Habbal MZ; Mikati MA; Zaatari GE; Cortas NK; Daher RT
    Clin Biochem; 2013 Dec; 46(18):1787-92. PubMed ID: 23994778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of potential interferents of methylmalonic acid: A previously unrecognized pitfall in clinical diagnostics and newborn screening.
    Monostori P; Godejohann M; Janda J; Galla Z; Rácz G; Klinke G; Szatmári I; Zsidegh P; Kohlmüller D; Kölker S; Hoffmann GF; Gramer G; Okun JG
    Clin Biochem; 2023 Jan; 111():72-80. PubMed ID: 36202155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Outcomes of patients with combined methylmalonic acidemia and homocystinuria after treatment].
    Huang Z; Han LS; Ye J; Qiu WJ; Zhang HW; Gao XL; Wang Y; Ji WJ; Li XY; Gu XF
    Zhonghua Er Ke Za Zhi; 2013 Mar; 51(3):194-8. PubMed ID: 23751581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The markers of the organic acidemias and their ratios in healthy neonates in Serbian population.
    Beletić A; Tijanić A; Chrastina P; Nikolić T; Stefanović A; Stanković S
    Drug Metab Pers Ther; 2022 Sep; 37(3):271-275. PubMed ID: 35254746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Newborn screening for inborn errors of metabolism in a northern Chinese population.
    Liu G; Liu X; Lin Y
    J Pediatr Endocrinol Metab; 2023 Mar; 36(3):278-282. PubMed ID: 36662638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.